Atticus Wealth Management
ABBV icon

Atticus Wealth Management’s AbbVie ABBV Stock Holding History

Atticus Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$921K Buy
3,519
+336
+11% +$86.1K 0.2% 68
2026
Q2 		$801K Sell
3,183
-32
-1% -$6.88K 0.19% 77
2026
Q1 		$699K Sell
3,215
-394
-11% -$87.4K 0.19% 85
2025
Q4 		$825K Sell
3,609
-113
-3% -$25.7K 0.2% 73
2025
Q3 		$862K Buy
3,722
+24
+0.6% +$4.89K 0.22% 67
2025
Q2 		$686K Sell
3,698
-42
-1% -$7.81K 0.19% 69
2025
Q1 		$784K Sell
3,740
-37
-1% -$7.19K 0.26% 54
2024
Q4 		$671K Buy
3,777
+3
+0.1% +$552 0.21% 61
2024
Q3 		$745K Buy
3,774
+60
+2% +$11.2K 0.24% 52
2024
Q2 		$637K Sell
3,714
-274
-7% -$45.4K 0.21% 56
2024
Q1 		$726K Sell
3,988
-238
-6% -$41K 0.24% 52
2023
Q4 		$655K Sell
4,226
-1,011
-19% -$147K 0.23% 55
2023
Q3 		$781K Buy
5,237
+6
+0.1% +$881 0.3% 48
2023
Q2 		$705K Buy
5,231
+5
+0.1% +$733 0.26% 57
2023
Q1 		$833K Buy
5,226
+55
+1% +$8.41K 0.32% 48
2022
Q4 		$836K Sell
5,171
-52
-1% -$7.97K 0.34% 52
2022
Q3 		$800K Hold
5,223
– – 0.39% 40
2022
Q2 		$800K Buy
5,223
+560
+12% +$85.6K 0.33% 52
2022
Q1 		$756K Buy
4,663
+1,612
+53% +$234K 0.28% 59
2021
Q4 		$413K Sell
3,051
-617
-17% -$72.9K 0.16% 86
2021
Q3 		$396K Buy
3,668
+8
+0.2% +$914 0.17% 69
2021
Q2 		$412K Buy
3,660
+284
+8% +$32K 0.18% 75
2021
Q1 		$365K Buy
3,376
+2
+0.1% +$214 0.17% 78
2020
Q4 		$362K Buy
3,374
+405
+14% +$38.9K 0.18% 70
2020
Q3 		$260K Buy
2,969
+314
+12% +$29.6K 0.16% 75
2020
Q2 		$261K Sell
2,655
-524
-16% -$46.1K 0.17% 76
2020
Q1 		$242K Buy
3,179
+9
+0.3% +$767 0.2% 69
2019
Q4 		$281K Buy
+3,170
New +$263K 0.18% 70

Other funds holding ABBV

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $91.6B AUM 30% 1-Year Est. Return

Atticus Wealth Management's ABBV Position: Q3 2026 in Review

Atticus Wealth Management increased its AbbVie (ABBV) stake by 11% in Q3 2026, buying an estimated $86.1K and bringing the position to 3,519 shares worth $921K. The position accounts for 0.2% of the portfolio, ranked #68.

Atticus Wealth Management first reported a position in ABBV in Q4 2019 and has held it in 28 quarters since. 2,418 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Atticus Wealth Management held 3,519 shares of AbbVie worth $921K as of Q3 2026.
  • Atticus Wealth Management bought 336 AbbVie shares in Q3 2026, an estimated $86.1K.
  • AbbVie made up 0.2% of Atticus Wealth Management's portfolio in Q3 2026, its #68 holding.
  • Atticus Wealth Management first reported a position in AbbVie in Q4 2019 and has held it in 28 quarters since.
  • 2,418 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Atticus Wealth Management's 13F filing for Q3 2026, filed 20 Oct 2026.